Celgene sues Dr Reddy’s over Pomalyst generic
11-02-2021
BMS and Dr Reddy’s settle Revlimid suit with generics licence
22-09-2020
BMS to acquire Forbius in oncology expansion
27-08-2020
BMS partners with drug accelerator to launch biotech
05-02-2020
AbbVie to acquire Allergan for $63bn
25-06-2019
BMS pays $1.85bn for immuno-oncology programme
15-02-2018
Bristol-Myers Squibb buys Cormorant Pharmaceuticals
06-07-2016